194 related articles for article (PubMed ID: 38097734)
1. PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer.
Chauhan SS; Casillas AL; Vizzerra AD; Liou H; Clements AN; Flores CE; Prevost CT; Kashatus DF; Snider AJ; Snider JM; Warfel NA
Oncogene; 2024 Feb; 43(6):406-419. PubMed ID: 38097734
[TBL] [Abstract][Full Text] [Related]
2. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.
Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ
Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483
[TBL] [Abstract][Full Text] [Related]
4. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells.
Wang J; Anderson PD; Luo W; Gius D; Roh M; Abdulkadir SA
Oncogene; 2012 Apr; 31(14):1794-803. PubMed ID: 21860423
[TBL] [Abstract][Full Text] [Related]
5. RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition.
van der Meer R; Song HY; Park SH; Abdulkadir SA; Roh M
Clin Cancer Res; 2014 Jun; 20(12):3211-21. PubMed ID: 24771642
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Lipid Droplet-Peroxisome Proliferator-Activated Receptor α Axis Suppresses Cancer Stem Cell Properties.
Kuramoto K; Yamamoto M; Suzuki S; Togashi K; Sanomachi T; Kitanaka C; Okada M
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33466690
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.
Ha S; Iqbal NJ; Mita P; Ruoff R; Gerald WL; Lepor H; Taneja SS; Lee P; Melamed J; Garabedian MJ; Logan SK
Oncogene; 2013 Aug; 32(34):3992-4000. PubMed ID: 22986532
[TBL] [Abstract][Full Text] [Related]
8. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia.
Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Perez M; Muñoz-Galvan S; Cañamero M; Renner O; Carnero A
PLoS One; 2013; 8(4):e60277. PubMed ID: 23565217
[TBL] [Abstract][Full Text] [Related]
9. Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells.
Morales A; Greenberg M; Nardi F; Gil V; Hayward SW; Crawford SE; Franco OE
Lab Invest; 2021 Jul; 101(7):921-934. PubMed ID: 33824421
[TBL] [Abstract][Full Text] [Related]
10. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
[TBL] [Abstract][Full Text] [Related]
11. The PIM1 kinase promotes prostate cancer cell migration and adhesion via multiple signalling pathways.
Santio NM; Salmela M; Arola H; Eerola SK; Heino J; Rainio EM; Koskinen PJ
Exp Cell Res; 2016 Mar; 342(2):113-24. PubMed ID: 26934497
[TBL] [Abstract][Full Text] [Related]
12. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
Carcinogenesis; 2019 Mar; 40(1):52-60. PubMed ID: 30247545
[TBL] [Abstract][Full Text] [Related]
13. PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.
Torres-Ayuso P; Katerji M; Mehlich D; Lookingbill SA; Sabbasani VR; Liou H; Casillas AL; Chauhan SS; Serwa R; Rubin MR; Marusiak AA; Swenson RE; Warfel NA; Brognard J
Cell Chem Biol; 2024 Feb; 31(2):326-337.e11. PubMed ID: 38016478
[TBL] [Abstract][Full Text] [Related]
14. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma.
Wang J; Kim J; Roh M; Franco OE; Hayward SW; Wills ML; Abdulkadir SA
Oncogene; 2010 Apr; 29(17):2477-87. PubMed ID: 20140016
[TBL] [Abstract][Full Text] [Related]
15. The role of PIM1/PIM2 kinases in tumors of the male reproductive system.
Jiménez-García MP; Lucena-Cacace A; Robles-Frías MJ; Narlik-Grassow M; Blanco-Aparicio C; Carnero A
Sci Rep; 2016 Nov; 6():38079. PubMed ID: 27901106
[TBL] [Abstract][Full Text] [Related]
16. Sigma1 Regulates Lipid Droplet-mediated Redox Homeostasis Required for Prostate Cancer Proliferation.
Oyer HM; Steck AR; Longen CG; Venkat S; Bayrak K; Munger EB; Fu D; Castagnino PA; Sanders CM; Tancler NA; Mai MT; Myers JP; Schiewer MJ; Chen N; Mostaghel EA; Kim FJ
Cancer Res Commun; 2023 Oct; 3(10):2195-2210. PubMed ID: 37874216
[TBL] [Abstract][Full Text] [Related]
17. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.
Zemskova M; Lilly MB; Lin YW; Song JH; Kraft AS
Mol Cancer Res; 2010 Aug; 8(8):1126-41. PubMed ID: 20647331
[TBL] [Abstract][Full Text] [Related]
18. Nuclear PIM1 confers resistance to rapamycin-impaired endothelial proliferation.
Walpen T; Kalus I; Schwaller J; Peier MA; Battegay EJ; Humar R
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):24-30. PubMed ID: 23131564
[TBL] [Abstract][Full Text] [Related]
19. PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer.
Ruff SE; Vasilyev N; Nudler E; Logan SK; Garabedian MJ
Commun Biol; 2021 Oct; 4(1):1221. PubMed ID: 34697370
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α.
Marino JS; Stechschulte LA; Stec DE; Nestor-Kalinoski A; Coleman S; Hinds TD
J Biol Chem; 2016 Dec; 291(50):25776-25788. PubMed ID: 27784782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
